Worldwide Antinuclear Antibody Test Market Size, Opportunities for Revenue Growth, and Future Forecast
The Gobal Antinuclear Antibody Test Market is expected to reach $ 1,476.1 million, at a CAGR of 12.4%
(firmenpresse) - The Research Report on Antinuclear Antibody Test Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the market, along with revenue estimates & forecasts and market share analysis.
The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this ANA testing market.
The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market. The growth in this segment can majorly be attributed to the growth in the number of reagent rental agreements and increasing prevalence of autoimmune diseases.
According to Latest Market research report Published by MarketsandMarkets the
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007
Target Audience for this Report:
key players operating in the Global Antinuclear Antibody Test Market;
The major players in this market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).
Alere Inc. (U.S.) is the second-largest player in the global ANA testing market, with a share of 15.6%. Alere operates in more than 100 countries across the globe, including the U.S., Austria, Denmark, China, Brazil, Indonesia, South Africa, and Japan. The company focuses on new product launches to strengthen its portfolio in the ANA testing market.
Major Drivers Impacting the Antinuclear Antibody Test Market;
Global ANA Testing Market Segmentation:
Based on techniques, the Antinuclear Antibody Test Market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.
The end user segments in the market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share of the global ANA testing market. Growth in this segment can be attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, primarily due to easy access to reports and smooth logistics.
Request Research Sample Pages (Please provide your specific interest in this report so as to help you better):
https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007
Based on region, the global antinuclear antibody test market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 04.12.2019 - 01:25 Uhr
Sprache: Deutsch
News-ID 1554437
Anzahl Zeichen: 3938
contact information:
Contact person: shelly singh
Town:
northbook
Phone: 18886006441
Kategorie:
Research & Development
Typ of Press Release: Financial
type of sending: send
Date of sending: 04.12.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 598 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Worldwide Antinuclear Antibody Test Market Size, Opportunities for Revenue Growth, and Future Forecast
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
